Address: Av. Presidente Juscelino Kubitscheck, 1.830, Torre 3, 5º andar, Itaim Bibi, CEP.: 04543-900 – São Paulo – SP,Brazil
Tel: 0800 77 17017
Web: http://www.hypermarcas.com.br/
Hypermarcas is one of the largest consumer goods companies funded by Brazilian capital and has the largest and most diversified portfolio of brands, including a number of leading brands in their respective markets. Hypermarcas operates in four market segments, developing, manufacturing and distributing products that belong to a traditional and well-established portfolio of brands.
Hypermarcas has a sales and distribution system that covers all regions in Brazil through food retail, and pharmaceutical distribution channels. Each one of the company’s lines of business has a dedicated and specialized sales team, supported by a robust network of promoters, as well as sales representatives who visit medical practices for sales of medicines.
Hypermarcas currently operate 19 plants in nine industrial complexes located in the states of Goiás, Santa Catarina and São Paulo. Hypermarcas’ portfolio of brands and products has an established consumer demand and historically has provided the company with a consistent revenue stream.
Hypermarcas has a professional management team and controlling shareholders with broad experience and know-how in the consumer goods industry. The company has experience in identifying, acquiring, and integrating new businesses in this sector into the Company, as well as executing growth and marketing strategies, factors which have allowed Hypermarcas to increase its portfolio of brands and products. Hypermarcas’ growth strategy is defined by a combination of organic growth with acquisitions, having 28 acquisitions been completed since operations started, aiming at expanding the portfolio of brands and products.
Pharmaceutical; over-the-counter medications (OTC), prescribed medications (Rx) and generics – Benegrip, Engov, Rinossoro, Doril, Tamarine, Atroveran; Beauty and Personal Care: Monange, Paixão, Risqué, Bozzano, Jontex, Olla, Cenoura & Bronze; Food Products: Finn, Zero Cal, Salsaretti; Home Care Products: Assolan, Mat Inset.
Hypermarcas is a huge, diversified corporation that sells everything from shampoo, to medicine. Would you consider it more of a consumer goods company that happens to sell pharmaceuticals, or the…
Many international CROs entered Brazil in the past few years, whereas Quintiles made its first move in Brazil in 1996. What was the strategic decision behind entering Brazil at that…
PGS is a member of ABRACRO, but is in a unique position as both a CRO and a service provider to CROs and pharmaceutical companies. Can you elaborate on the…
The government recently released the ‘BrasilMaior’ plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry…
The government recently released the BrasilMaior plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry…
We met recently with Minister Pimentel when he launched his BrasilMaior plan, whose slogan was “Innovate to Compete. Compete to Grow.” If you had to make a recommendation to increase…
When we last interviewed you in 2007, you said, “The generics business is a very exciting one,” but you “regret[ted] that the Government is not doing enough work to promote…
As I was doing research on your company, GC-2, I was unable to find a lot of information since it is a rather new company. Could you bring me up…
In a past interview, you said that Ipsen is different than the “Big Pharmas” who have entered Brazil by acquisition. You’ve taken a different tack since arriving as one of…
There is little publicly available information on your personal history and the founding of Meizler. Can you share that story for our readers? Everybody has a story – unless they’re…
Diabetes affects an estimated 6 million Brazilians, a figure which is expected to double by 2025, in line with many other developing nations. Like many other “rich-country” diseases, there is…
An important topic in Brazil is access to drugs. In recent interviews we have spoken about a third of MS patients being treated, or 10% of hypertensives having their condition…
Yesterday the Ministry of Health released an article stating that chronic diseases now account for 70% of all deaths in Brazil, and welcoming suggestions for the national plan against chronic…
See our Cookie Privacy Policy Here
